DRI Healthcare Trust's latest earnings report shows a significant miss against expectations, raising questions about its future growth.
On August 7, 2026, DRI Healthcare Trust (DHT-UN.TO) reported its second-quarter earnings, revealing an EPS of $0.56, which fell short of analyst estimates of $0.60. This 6.67% miss is notable, especially considering the company's recent history of outperforming expectations in two of the last four quarters.
Recent earnings trend
Advertisement
DRI Healthcare Trust
DHT-UN.TO
DHT-UN.TO
DRI Healthcare Trust
WealthAwesomeAdvertisement
Market cap
$991.95M
Div. yield
2.40%
Div. / share
$0.41
52W high
$19.75
52W low
$13.41
1W change
+4.04%
Beta
0.67
Analyst Price Targets
Based on analyst covering DHT-UN
Wall Street analysts forecast DHT-UN stock price to rise 25.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$22.60
+25.5% Upside
Current Price
C$18.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHT-UN's historical volatility
30-Day Vol
31.7%
Annualized
90-Day Vol
27.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$21.53
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$19.11 | C$17.14 โ C$21.32 |
| 60 trading days | C$20.29 | C$17.38 โ C$23.68 |
| 90 trading days | C$21.53 | C$17.82 โ C$26.02 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 4 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-05 | โ | 0.5500 | โ |
| 2026-06-30 | 2026-08-07 | 0.5600 | 0.6000 | -6.7% |
| 2026-03-31 | 2026-05-14 | 0.6800 | 0.5500 | +23.6% |
| 2025-12-31 | 2026-03-03 | 0.7800 | 0.5200 | +50.0% |
| 2025-09-30 | 2025-11-05 | 0.5500 | 0.5500 | +0.0% |
| 2025-06-30 | 2025-08-13 | 0.5100 | 0.4800 | +6.3% |
Advertisement
Investor takeaway: While DRI Healthcare Trust's earnings miss raises concerns, the company has shown strong growth in total income and cash receipts, suggesting potential for recovery. Investors should pay attention to the strategic initiatives discussed in the earnings call, particularly the anticipated royalties from newly approved treatments.
EPS Misses by 6.7%, Total Income Up 13%
The reported EPS of $0.56 was below the consensus estimate of $0.60, indicating a possible gap in operational efficiency or market conditions affecting profitability.
Bull case
The company reported record Q2 results, with total income rising 13% year-over-year to $50.1 million and adjusted EBITDA climbing 40%. The strategic monetization of its Ekterly investment has improved liquidity for future growth initiatives, and the expected royalties from Lumvoa could provide additional revenue streams.
Bear case
Despite strong revenue growth, the EPS miss suggests potential challenges in managing costs or achieving profitability. The company's negative trailing twelve-month EPS and profit margin raise concerns about its long-term financial health.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
